Compare DexCom, Inc. (DXCM) vs SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs SP Funds S&P 500 Sharia Industry Exclusions ETF — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $60.77 (market cap $3.39B). The key difference: DexCom, Inc. is far larger — about 9.4× SP Funds S&P 500 Sharia Industry Exclusions ETF's market cap, and SP Funds S&P 500 Sharia Industry Exclusions ETF is trading nearer its 52-week high, DexCom, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and SP Funds S&P 500 Sharia Industry Exclusions ETF for 64 Days on average.
| DXCM | SPUS | |
|---|---|---|
Market Cap | $31.86B | $3.39B |
Volume | 3,607,070 | 349,184 |
Sector | Health | Broad Market / Factor |
52-Week High | $92.34 | $61.15 |
52-Week Low | $54.84 | $46.65 |
Typical Hold Time | 62 Days | 64 Days |
Enterprise Value | $31.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth from $2.9B in 2022 to $4.66B in 2025. Profit margins have expanded significantly to 17.93%, while analyst sentiment remains overwhelmingly positive with 81% buy ratings. Recent news highlights the company's focus on Type 2 diabetes market expansion and leadership appointments.
DXCM presents a compelling growth story with expanding profitability and market opportunities, though elevated valuation multiples and technical bearish signals warrant caution. The consensus price target of $95.07 suggests 13% upside potential, but investors should monitor competitive pressures and reimbursement challenges in the CGM market.
SPUS (SP Funds S&P 500 Sharia Industry Exclusions ETF) trades at $60.77, down 0.49% with a bearish short-term technical signal despite bullish moving averages. The ETF shows consistent dividend distributions of $0.03 per share. Technical indicators show mixed signals with RSI suggesting overbought conditions while ADX indicates strong trend momentum.
The ETF faces headwinds from significant short interest growth (174.5% increase in September 2026) while maintaining its Sharia-compliant investment strategy. Key risks include market volatility and sector concentration, though the S&P 500 exposure provides diversification benefits for investors seeking compliant equity exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About SP Funds S&P 500 Sharia Industry Exclusions ETF
SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →
